MetLife (MET) EVP & Chief Accounting Officer granted 12,485 shares

Rhea-AI Filing Summary

MetLife Inc. EVP & Chief Accounting Officer Adrienne Karen O'Neill received a grant of 12,485 shares of Common Stock on April 30, 2026. The award is described as a restricted stock unit grant under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. Following this compensation-related acquisition, she directly holds 27,042 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider O'Neill Adrienne Karen

Role EVP & Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	12,485	$0.00	--

Holdings After Transaction: Common Stock — 27,042 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 12,485 shares Shares held after transaction: 27,042 shares Grant price per share: $0.0000 per share

3 metrics

Shares granted 12,485 shares Restricted stock unit award on April 30, 2026

Shares held after transaction 27,042 shares Total direct Common Stock holdings after grant

Grant price per share $0.0000 per share Reported transaction price for awarded shares

Key Terms

Restricted stock unit, Stock and Incentive Compensation Plan, Form 4

3 terms

Restricted stock unit financial

"Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Stock and Incentive Compensation Plan financial

"Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Neill Adrienne Karen

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		A		12,485	A	(1)	27,042	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.

Remarks:

	/s/ Morgan Keehner-Jones Mayes, Attorney-in-fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MetLife (MET) report for Adrienne Karen O'Neill?

MetLife reported a stock grant to Adrienne Karen O'Neill. She received 12,485 shares of Common Stock as a restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, increasing her direct holdings to 27,042 shares.

Was the MetLife (MET) Form 4 transaction a stock purchase or a grant?

The Form 4 transaction was a grant, not an open-market purchase. Adrienne Karen O'Neill received 12,485 shares coded as a grant or award acquisition, with a reported price per share of $0.0000, indicating a compensation-related award.

How many MetLife (MET) shares does Adrienne Karen O'Neill hold after this award?

After the award, Adrienne Karen O'Neill holds 27,042 shares. The Form 4 shows she acquired 12,485 shares of Common Stock, bringing her total direct ownership position to 27,042 shares following the April 30, 2026 transaction.

What plan governed the restricted stock unit award reported by MetLife (MET)?

The award was granted under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. The Form 4 footnote specifies that the 12,485-share restricted stock unit award was issued pursuant to this stock and incentive compensation program.

Does the MetLife (MET) Form 4 show any stock sales by Adrienne Karen O'Neill?

No stock sales are reported for this transaction. The filing lists a single acquisition coded as a grant or award of 12,485 shares of Common Stock, with no dispositions or sales disclosed in the provided data.